Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells

Cell Biology International

Volumn 36, Issue 10, 2012, Pages 917-922

  Cen, Yan Hui ^a   Guo, Wen Wen ^a   Luo, Bin ^a   Lin, Yong Da ^a   Zhang, Qing Mei ^a   Zhou, Su Fang ^a   Luo, Guo Rong ^a   Xiao, Shao Wen ^a   Xie, Xiao Xun ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cancer testis antigen; Mesenchymal stem cells; OY TES 1

Indexed keywords

BETA1 INTEGRIN; CANCER TESTIS ANTIGEN; CD14 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HLA DR ANTIGEN; MESSENGER RNA; OY TES 1 PROTEIN; SMALL INTERFERING RNA; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL CYCLE ARREST; CELL MIGRATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MESENCHYMAL STEM CELL; OY TES 1 GENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

APOPTOSIS; BONE MARROW CELLS; CARRIER PROTEINS; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; RNA INTERFERENCE;

EID: 84867158952     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20120037     Document Type: Article

References (12)

1. Baba T, Michikawa Y, Kashiwabara S, Arai Y. Proacrosin activation in the presence of a 32-kDa protein from boar spermatozoa. Biochem Biophys Res Commun 1989;160:1026-32.
2. Cronwright G, Le Blanc K, Gotherstrom C, Darcy P, Ehnman M, Brodin B. Cancer/testis antigen expression in human mesenchymal stem cells: downregulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. Cancer Res 2005;65:2207-15.
3. Fang EF, Zhang CZ, Fong WP, Ng TB. RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways. Apoptosis 2012;17:377-87.
4. Gierstorff M, Burns JS, Nielsen O, Kassem M, Ditzel H. Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy. Am J Pathol 2009;175:314-23.
5. Kubuschok B, Xie X, Jesnowski R, Preuss KD, Romeike BF, Neumann F, et al. Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis. Int J Cancer 2004;109:568-75.
6. Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci USA 2001;98:3282-7.
7. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immunol 2004;4:1.
8. Silva WA, Jr., Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003;21:661-9.
9. Smith HA, McNeel DG. The SSX family of cancer-testis antigens as target proteins for tumor therapy. Clin Dev Immunol 2010;2010:150591.
10. Spampanato C, De Maria S, Sarnataro M, Giordano E, Zanfardino M, Baiano S, et al. Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and downregulation of BCL-2 gene expression. Int J Oncol 2012;40:935-41.
11. Zhang Y, Liu H, Jin J, Zhu X, Lu L, Jiang H. The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells. Anticancer Drugs 2010;21:494-501.
12. Zhou SF, Xie XX, Bin YH, Lan L, Chen F, Luo GR. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients. Clin Chim Acta 2006;366:274-80.